Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy

Clinical Chemistry

Volumn 59, Issue 1, 2013, Pages 327-329

  Dhesy Thind, Sukhbinder ^a,b   Kumar, Vikaash ^c   Snider McNair, Aidan ^a   Shortt, Colleen ^a   Mukherjee, Som D ^a,b   Ellis, Peter ^a,b   Pond, Gregory R ^a   Kavsak, Peter A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PACLITAXEL; TRASTUZUMAB; TROPONIN T; TUMOR MARKER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE NECROSIS; HUMAN; INFLAMMATION; LETTER; QUALITY CONTROL;

ANTIBODIES, MONOCLONAL, HUMANIZED; BIOLOGICAL MARKERS; CHEMOTHERAPY, ADJUVANT; HUMANS; INFLAMMATION; MYOCARDIUM;

EID: 84872018707     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.192419     Document Type: Letter

References (5)

1. Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, et al. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem 2012;58:1049-54.
2. Onitilo AA, Engel JM, Stankowski RV, Liang H, Berg RL, Doi SA. High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumabinduced cardiotoxicity in HER2-positive earlystage breast cancer: a pilot study. Breast Cancer Res Treat 2012;134:291-8.
3. Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin Chem 2007;53:2112-8.
4. Koerbin G, Tate J, Potter JM, Cavanaugh J, Glasgow N, Hickman PE. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin Chem Lab Med 2012;50:871-8.
5. Scherr J, Braun S, Schuster T, Hartmann C, Moehlenkamp S, Wolfarth B, et al. 72-h Kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc 2011;43:1819-27.